Form 4: Vistra CEO James Burke Sells VST Shares Under 10b5-1 Plan

Vistra Corp. President and CEO James A. Burke executed sales of common stock totaling 42,742 shares in early October 2025, following the exercise of employee stock options, under a pre-arranged 10b5-1 trading plan.

Summary

• James A. Burke, President and CEO of Vistra Corp., reported transactions involving VST common stock on October 2 and October 3, 2025.
• On October 2, 2025, Burke exercised 24,000 employee stock options at an exercise price of $19.68 per share.
• Concurrently, he sold 21,371 shares of common stock at a weighted-average price of $204.06 per share, which included 2,322 shares for cashless exercise and 8,534 shares to cover taxes.
• On October 3, 2025, Burke exercised another 24,000 employee stock options at $19.68 per share.
• He subsequently sold 21,282 shares at a weighted-average price of $204.82 per share and an additional 89 shares at $205.73 per share. These sales included 2,314 shares for cashless exercise and 8,538 shares for taxes.
• All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2025.
• Following these transactions, Burke directly owns 259,073 shares of common stock and indirectly owns 701,514 shares through JAMEB, LP, 34,000 shares through the James A. Burke 2012 Irrevocable Trust, and 259 shares through the Marti E. Burke 2012 Irrevocable Trust.
• He also holds 362,052 unexercised 2018 Employee Stock Options, which have an expiration date of April 9, 2027.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider sales can sometimes be viewed negatively, these transactions were conducted under a pre-arranged 10b5-1 plan, which mitigates concerns about opportunistic selling. The sales are also tied to the exercise of options, a common compensation realization event.

Positives

• The executive exercised stock options, indicating the realization of previously granted compensation.
• The sale prices ($204.06, $204.82, $205.73) are significantly higher than the exercise price ($19.68), demonstrating substantial personal gain for the executive.
• Transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which provides an affirmative defense against insider trading allegations and indicates planned, rather than opportunistic, sales.

Negatives

• Significant sales by a high-ranking executive (President and CEO) could be interpreted negatively by the market, potentially signaling a belief that the stock price may not rise significantly further in the short term.
• The total number of shares sold (42,742 shares) represents a notable reduction in direct holdings.

Future Outlook

The filing indicates the expiration date of some employee stock options (April 9, 2027) and their vesting schedule (50% 4 years from grant, remaining 50% 5 years from grant), which outlines the executive's future compensation realization structure. The adoption of a Rule 10b5-1 plan on June 12, 2025, also represents a forward-looking strategy for pre-arranged equity transactions.

Industry Context

Form 4 filings are standard regulatory disclosures for insider transactions across all publicly traded companies. These transactions reflect an executive's personal financial planning and compensation realization, rather than broader industry trends or company-specific operational performance.

Corporate Governance

Related Party Transactions

• Indirect beneficial ownership of 701,514 common shares through JAMEB, LP, a limited partnership jointly owned by the reporting person and his spouse.
• Indirect beneficial ownership of 34,000 common shares through the James A. Burke 2012 Irrevocable Trust.
• Indirect beneficial ownership of 259 common shares through the Marti E. Burke 2012 Irrevocable Trust.

Stakeholder Impact

• Shareholders: May interpret the executive's sales as a signal, potentially leading to short-term price volatility, though the pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling.
• Management: The transactions reflect the realization of executive compensation and personal financial planning.

Key Dates

Keywords

Vistra Corp, VST, James A. Burke, CEO, President, insider trading, Form 4, stock options, share sale, 10b5-1 plan, executive compensation